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SCIENTIFIC OPINION 
Scientific Opinion on the re-evaluation of montan acid esters (E 912) as a 
food additive
1 
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS)
2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following a request from the European Commission, the EFSA Panel on Food Additives and Nutrient Sources 
added to Food (ANS) was asked to deliver a scientific opinion re-evaluating the safety of montan acid esters (E 
912) when used as a food additive. Montan acids are extracted from oxidised montan wax and esterified with 
ethylene glycol, 1,3-butanediol or triols, to form montan acid esters. Montan acid esters are authorised only for 
the  surface  treatment  of  fresh  fruits.  No  data,  specifically  for  montan  acid  esters,  on  toxicokinetics  and 
reproductive  and  developmental  toxicity  were  available.  The  available  data  on  short-term  and  subchronic 
toxicity,  genotoxicity  and  chronic  toxicity  and  carcinogenicity  were  limited.  Important  deficiencies  in  the 
available studies on chronic toxicity and carcinogenicity were noticed. The data requested in the 1990s (i.e. 
chromosomal aberration in vitro, reproduction and teratogenicity studies, material characteristics, impurities, 
presence of PAHs) were not submitted. Furthermore no data were submitted following an EFSA public call for 
data in 2012. The Panel identified some summary data in the European Chemicals Agency database (ECHA) on 
registered substances that might have been relevant for the assessment of montan acid esters but the original 
study reports were not made available to EFSA. Based on these limitations in the toxicological database the 
Panel concluded that montan acid esters as a food additive could not be evaluated. 
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SUMMARY  
Following a request from the European Commission, the EFSA Panel on Food Additives and Nutrient 
Sources added to Food (ANS) was asked to deliver a scientific opinion on the re-evaluation of montan 
acid esters (E 912) as a food additive. 
The Panel was not provided with a newly submitted dossier on montan acid esters and no new data 
were  submitted  following  a  public  call  for  data.  The  present  evaluation  is  based  on  previous 
evaluations and on additional literature that became available since then. Not all original studies on 
which previous evaluations were based were available for re-evaluation but the Panel had access to 
information submitted to the EU Scientific Committee on Food (SCF). 
Montan acid esters (E 912) are waxes of various chemical compositions. Montan acids are isolated 
from montan wax, a bituminous product extracted from lignite, and then esterified with diols such as 
ethylene glycol and 1,3-butylene glycol or with triols such as glycerol. 
The Panel noted that benzene is used as solvent in the manufacturing process. Benzene is genotoxic 
and is classified by the International Agency for Research on Cancer (IARC) and EU as a human 
carcinogen.  
The Panel recommended that benzene should not be used for the manufacturing of montan acid esters. 
The Panel noted that the specifications did not include properties such as melting point and solubility, 
which would help identify the substance. The Panel considered that the starting  materials for the 
production of the montan acid esters would justify either a requirement for limits for poly-aromatic 
hydrocarbons (PAHs), or proof that the extraction procedure and the subsequent oxidation steps in the 
manufacturing process would prevent any residual contamination with such substances. 
No data on absorption, distribution, metabolism, and excretion (ADME) of montan acid esters were 
available for the present evaluation.  
Feeding studies in the dog and the rat have been performed with different types of test mixtures that 
fall within the definition of montan acid esters, E 912. In a 90-day study in the rat and in two 90-day 
studies in the dog no treatment related effects were found at doses up to 1660 mg/kg bw/day for the 
dog and up to about 4000 mg/kg bw/day for the rat.  
The Panel considered that the two 2-year studies on montan acid esters (Wax E and Wax KPS) were 
not suitable for risk assessment due to the limitations in the studies or the material tested. Two types of 
commercial montan acid esters (Wax E and WE4) gave negative results in the Ames test.  
No reproductive and developmental toxicity studies are available. 
The Panel noted that: 
-  no data on toxicokinetics and reproductive and developmental toxicity of montan acid esters 
were available, 
-  the available data on short-term and subchronic toxicity, genotoxicity and chronic toxicity and 
carcinogenicity were limited,  
-  the data requested by the SCF in the late 1990s (i.e. chromosomal aberration study in vitro, 
reproduction  and  teratogenicity  studies,  description  of  the  material,  including  impurities, 
absence of PAHs and/or a specification) have not been submitted,  
-  No data were submitted following an EFSA public call for data in 2012. The Panel identified 
some  summary  data  in  the  European  Chemicals  Agency  (ECHA)  database  on  registered Re-evaluation of montan acid esters (E 912) as a food additive 
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substances  that might have been relevant for the assessment of montan acid esters but t he 
original study reports were not made available to EFSA. 
Based on these limitations in the toxicological database the Panel concluded that montan acid esters as 
a food additive could not be evaluated. 
The Panel noted that benzene is reported to be used as solvent in the manufacturing process. Benzene 
is not authorised as an extraction solvent in the production of foodstuffs and ingredients (EU Directive 
No 2009/32/EU),. Benzene is genotoxic and is classified by IARC and EU as a human carcinogen and 
therefore it should not be used for the manufacturing of montan acid esters. Re-evaluation of montan acid esters (E 912) as a food additive 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
Regulation (EC) No 1333/2008
4 of the European Parliament and of the Council on food additives 
requires that food additives are subject to a safety evaluation by the European Food Safety Authority 
(EFSA) before they are permitted for use in the European Union. In addition, it is foreseen that food 
additives must be kept under continuous observation and must be re-evaluated by the EFSA.  
For this purpose, a programme for the re -evaluation of food additives that were already permitted in 
the European Union before 20 January 2009 has been set up under the Regulation (EU) No 257/2010
5. 
This Regulation also foresees that food additives are re -evaluated whenever necessary in light of 
changing conditions of use and new scientific information. For efficiency and practical purposes, the 
re-evaluation should, as far as possible, be conducted by group of food additives according to the main 
functional class to which they belong. 
The order of priorities for the re-evaluation of the currently approved food additives should be set on 
the basis of the following criteria: the time since the last evaluation of a food additive by the Scientific 
Committee on Food (SCF) or by EFSA, the availability of new scientific evidence, the extent of use of 
a food additive in food and the human exposure to the food additive taking als o into account the 
outcome of the Report from the Commission on Dietary Food Additive Intake in the EU
6 of 2001. The 
report  “Food  additives  in  Europe  2000
7” submitted by the Nordic Council of Ministers to the 
Commission, provides additional information for the prioritisation of additives for re-evaluation. As 
colours were among the first additives to be evaluated, these food additives should be re-evaluated 
with the highest priority. 
In 2003, the Commission already requested EFSA to start a systematic re-evaluation of authorised 
food additives. However, as a result of the adoption of Regulation (EU) 257/2010 the 2003 Terms of 
Reference are replaced by those below. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The Commission asks the European Food Safety Authority to re-evaluate the safety of food additives 
already permitted in the Union before 2009 and to issue scientific opinions on these additives, taking 
especially into account the priorities, procedure and deadlines that are enshrined in the Regulation 
(EU) No 257/2010 of 25 March 2010 setting up a programme for the re-evaluation of approved food 
additives in accordance with the Regulation (EC) No 1333/2008 of the European Parliament and of the 
Council on food additives. 
                                                       
4 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives, OJ 
L 354, 31.12.2008, p. 16.   
5 Commission Regulation (EU) No 257/2010 of 25 March 2010 setting up the program for the re-evaluation of approved food 
additives in accordance with Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food 
additives, OJ L 80, 26.03.2010, p.19.   
6 Report from the Commission on Dietary Food Additive Intake in the European Union, Brussels, 01.10.2001, COM (2001)  
542 final. 
7 Food Additives in Europe 2000, Status of safety assessments of food additives presently permitted in the EU, Nordic 
Council of Ministers. TemaNord 2002:560. Re-evaluation of montan acid esters (E 912) as a food additive 
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ASSESSMENT 
1.  Introduction 
The present opinion deals with the re-evaluation of the safety of montan acid esters (E 912) when used 
as a food additive. 
Montan acid esters (E 912) are waxes of various chemical compositions authorised as a food additive 
in the EU according to Annex II of EC Regulation 1333/2008.  
The Panel on Food Additives and Nutrient Sources added to Food (ANS) was not provided with a 
newly submitted dossier on montan acid esters and no new data were submitted to the European Food 
Safety Authority (EFSA) following a public call for data in 2012
8. The Panel based its evaluation on 
previous evaluations and on additional literature that became available since then . The Panel noted 
that not all original studies on which previous evaluations were based were available for re-evaluation. 
The Panel had access to information submitted to the EU Scientific Committee on Food (SCF). 
2.  Technical data 
2.1.  Identity of the substance 
Montan acid esters (E 912) are complex mixtures that are described as “montan acids and/or esters 
with ethylene glycol and/or 1,3-butanediol and/or glycerol” (TemaNord, 2002).  
In  Figure  1  the  structural  formula  of  montanic  acid  (octacosanoic  acid,  C28H56O2,  CAS  Registry 
Number 506-48-9) is shown. From this basic structure the different montan acid esters can be derived.  
 
Figure 1. Structural formula of montanic acid 
Montan wax acids (CAS Registry Number 68476-03-9) are prepared from crude montan wax and may 
be esterified with ethylene glycol, 1,3-butanediol or triols such as glycerol, to form the food additive E 
912. 
The Panel noted that montan acid esters (E 912) are a group of substances with different CAS Registry 
Numbers. These CAS Registry Numbers include, among others, CAS Registry Number 73138-45-1 
(ethylene  glycol  monomontanate),  CAS  Registry  Number  68476-38-0  (glyceryl  montanate),  CAS 
Registry  Number  73138-44-0  (montan  wax  acid,  1,3-butanediol  diester),  CAS  Registry  Number 
93763-20-3 (fatty acids, montan- wax, esters with 1, 3- butanediol). 
The source material, montan wax (CAS Registry Number 8002-53-7; EINECS Number 232-313-5) 
consists of non-glyceride carboxylic acid esters (C24- C30; 62 - 68 % w/w), free long-chain organic 
acids (22–26 %), long-chain alcohols, ketones, and hydrocarbons (7–15 %), and resins (Heinrichs, 
2005). 
                                                       
8 Call for scientific data on montan acid esters (E 912). (http://www.efsa.europa.eu/en/dataclosed/call/120215a.htm). Re-evaluation of montan acid esters (E 912) as a food additive 
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Because of its origin, montan wax is classified as a mineral wax. Chemically however, it is more 
related to the hard vegetable waxes, such as carnauba wax, than to petroleum waxes. The composition 
of the montan wax varies depending on the geographical area (Bennett, 1975; Matthies, 2001). 
Synonyms for montan acid esters (E 912) are: fatty acid, montan wax; montan acid wax; waxes, 
montan fatty acids; fatty acids, montan-wax, ethylene esters; ethylene glycol monomontanate; glyceryl 
montanate; montan wax acid; butylene glycol montanate; 1,3-butanediol diester. 
A list of a number of esters of montan acids is given in Annex 1. 
2.2.  Specifications 
Commission Regulation (EU) No 231/2012 of 9 March 2012 laying down specifications for food 
additives listed in Annexes II and III to Regulation (EC) No 1333/2008 of the European Parliament 
and of the Council lays down specifications for montan acid esters (E 912) used as food additives. 
These specifications are listed in Table 1. The Joint FAO/WHO Expert Committee on Food Additives 
(JECFA) has not yet set specifications for montan acid esters (E 912). 
Table 1:   Specifications established for montan acid esters (E 912) by Commission Regulation (EU) 
No 231/2012. 
Montan acid esters (E 912)  Commission Regulation (EU) No 231/2012 
Definition 
Montan acids and/or esters with ethylene glycol and/or 1,3-
butanediol and/or glycerol 
Chemical name  Montan acid esters 
Description  Almost white to yellowish flakes, powder, granules or pellets 
Identification   
Density (20 
oC)  0.98-1.05 g/cm
3 (20°C) 
Drop point
1  Greater than 77 
oC 
Purity   
Acid value
2  Not more than 40  
Glycerol  Not more than 1 % (by gas chromatography) 
Other polyols  Not more than 1 % ( by gas chromatography) 
Other wax types  Not detectable (by differential scanning calorimetry and/or 
infrared spectroscopy) 
Arsenic  Not more than 2 mg/kg 
Chromium  Not more than 3 mg/kg 
Lead  Not more than 2 mg/kg 
1 The drop melting point of wax is the temperature at which the wax passes from a semi-solid state to a liquid state and drops 
from the thermometer used in making the determination under defined conditions. 
2 The Acid Value (AV) is defined as the mass of KOH (in mg) required to neutralise the acid groups contained in 1 g Dry 
Substance (DS). 
The Panel noted that the above specifications do not include properties such as melting point and 
solubility. For ethylene glycol  montanate (CAS Registry Number 73138-45-1) a  melting point of 
about 76-78°C, a boiling point in the range of >120-150°C (decomposition) and a density of 1.01-1.03 
g/cm³ (20°C) have been described. Ethylene glycol montanate has a very low solubility in water (EC, 
2000).  
The Panel also noted that there is a need to extend the specifications of montan acid esters (E 912) 
with  respect  to  the  percentage  of  free  acids  and  the  level  of  calcium  in  the  final  substance,  the Re-evaluation of montan acid esters (E 912) as a food additive 
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residuals carried over from the manufacturing process (e.g. components of the lignite, residues  of 
resins, residues of asphaltenes
9, residues of extraction solvents e.g. benzene).  
The Panel noted that benzene is reported to be used as solvent in the manufacturing process. Benzene 
is not authorised as an extraction solvent in the production of foodstuffs and ingredients (EU Directive 
No 2009/32/EU)
10. Benzene is genotoxic and is classified by the International Agency for Research on 
Cancer  (IARC)  and  EU  as  a  human  carcinogen  and  therefore  it  should  not  be  used  for  the 
manufacturing of montan acid esters. 
The Panel considered that the starting materials for the production of the montan acid esters  would 
justify either a requirement for  limits for  undesired residuals carried over from the manufacturing 
process (e.g. PAHs), or proof that the extraction procedure and the subsequent oxidation steps in the 
manufacturing process would prevent any residual contamination with such substances. 
2.3.  Manufacturing process 
Montan wax is produced by solvent extraction of lignite
11 or brown coal. The lignite is crushed , 
screened to remove fine powder, and dried. The crude wax is then extracted with a solvent mixture 
and recovered by distillation of the solvent. Various solvents may be used; in one method , described 
by Bennett (1975), an azeotropic mixture of about 85 % benzene and 15 % ethyl alcohol is used. The 
solvents are evaporated in several steps and the wax melt is pelleted or poured into moulds. The crude 
montan wax is a black-brown, hard, brittle product with a conchoidal fracture
12 pattern. Crude montan 
wax is refined by removing resins and asphalt enes with various organic solvents , distillation and 
fractionation. 
For the production of montan acids, the montan wax is oxidised with chromosulphuric acid mixtures. 
In this process, residues of resin and dark asphalt are oxidised to carbon dioxide or low molar mass, 
water-soluble compounds in a multistage oxidation process. Th e wax esters are simultaneously 
hydrolysed, the wax alcohols formed are oxidised to wax acids and the hydroxycarboxylic acids are 
oxidised to dicarboxylic acids. The resulting high carboxylic acid -containing product can then be 
esterified with different diols and triols to meet various technological needs, sometimes together with 
mild saponification with calcium hydroxide (Heinrichs, 2005). 
2.4.  Methods of analysis in foods 
No official method for analysing montan acid esters in food has been identified in a literature search. 
Regulation (EC) No 183/93
13 (1993) describes a method for determination of wax esters. The principle 
for the determination of phytyl - and geranylgeranyl fatty acids  relies on the  „addition of a suitable 
internal standard to the fat or oil, then fractionation by chromatography on a hydrated silica gel 
column. Recovery of the fraction eluted first under the test conditions (whose polarity is less than that 
of the triglycerides), then direct analysis by capillary column gas-liquid chromatography‟. 
A method for the determination of montan acid esters coating on fruits was described by Kröller 
(1973).  A  Differential  Scanning  Calorimetry  (DSC)  method  for  detecting  coatings  (beeswax, 
candelilla, wax, carnauba wax and shellac) on apples has been described (Ritter et al., 2001). 
                                                       
9Asphaltenes consist primarily of carbon, hydrogen, nitrogen, oxygen, and sulphur, as well as trace amounts of vanadium and 
 nickel. The C:H ratio is approximately 1:1.2 
10 Directive 2009/32/EC of the European Parliament and of the Council of 23 April 2009 on the approximation of the laws of 
the Member States on extraction solvents used in the production of foodstuffs and food ingredients. OJ L 141, 6.6.2009, p -3-
11. 
11 Lignite: yellow to dark brown coal formed from peat at shallow depths and temperatures lower than 100°C. 
12 „Conchoidal fracture‟ describes the way brittle materials break when they do not follow any natural planes of separation. 
13 Commission Regulation (EEC) No 183/93 of 29 January 1993 amending Regulation (EEC) No 2568/91 on the 
 characteristics of olive oil and olive-residue oil and on the relevant methods of analysis. OJ L 22, 30.1.1993, p. 58. Re-evaluation of montan acid esters (E 912) as a food additive 
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Tada et al. (2007) described a method for the determination of the different constituents of 10 ester-
type gum bases used as natural food additives in Japan (urushi wax
14, carnauba wax, candelilla wax, 
rice-bran wax, shellac wax, jojoba wax, bees wax, Japan wax, montan wax, and lanolin). 
2.5.  Reaction and fate in food 
No data on the reaction and fate of montan acid esters (E 912) in food have been submitted following 
a public call for data or found in the literature. The Panel considered that, generally, compounds of this 
chemical nature are stable in food matrices and that therefore it is unlikely that degradation or reaction 
with food components will take place to any significant extent. 
2.6.  Case of need and proposed uses 
Maximum Permitted Levels (MPLs) of montan acid esters have been defined in the Annex II of EC 
Regulation 1333/2008
15on food additives for use in foodstuffs. 
Currently, montan acid esters are authorised glazing agents in the EU permitted at  quantum satis in a 
limited number of foods. 
Table 2 summarises foods that are permitted to contain montan acid esters and the corresponding 
MPLs as set by Annex II of EC Regulation 1333/2008. 
Table 2:   MPLs  of  montan  acid  esters  in  foods  according  to  the  Annex  II  of  EC  Regulation 
1333/2008.  
Category 
number  Foods  Restrictions/exception 
Maximum level 
(mg/L or mg/kg as 
appropriate) 
04.1.1  Entire fresh fruit and 
vegetables 
only  surface  treatment  of  citrus  fruit,  melons, 
papaya, mango, avocado and pineapple  quantum satis 
2.7.  Reported use levels or data on analytical levels of montan acid esters  
Most food additives in the EU are authorised at a specific MPL. However, a food additive may be used 
at a lower level than the MPL. For those additives where no MPL is set and which are authorised as 
quantum satis, information on actual use levels is required. In the framework of Regulation (EC) No 
1333/2008 on food additives and of Regulation (EU) No 257/2010 regarding the re-evaluation of 
approved food additives, EFSA issued a public call for scientific data on montan acid esters including 
present use and use patterns (i.e. which food categories and subcategories, proportion of food within 
categories/subcategories  in  which  it  is  used,  actual  use  levels  (typical  and  maximum  use  levels), 
especially for those uses which are only limited by quantum satis). 
EFSA received no information on the usage of montan acid esters following the public call for data in 
2012. 
According to the SCF, the actual use levels of montan acid esters do not exceed 140 mg/kg fruit (SCF, 
1992). 
2.8.  Information on existing authorisations and evaluations 
The SCF has evaluated montan acid esters in various contexts.  
                                                       
14 Urushi: Japanese word which denotes a lacquer produced in East Asia from the sap of kiurushi trees (Lacquer tree, species 
of genus Toxicodendron ). 
15 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives. OJ 
L 354, pp 16-33. Re-evaluation of montan acid esters (E 912) as a food additive 
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Prior to 1992 the SCF concluded that a „temporary acceptance‟ should be given to substances where 
there was no reasoned doubt on their safety. Since, based on the available data at that time, montan 
acid  esters  did  not  show  adverse  effects  at  dietary  levels  of  up  to  5  %,  the  SCF  concluded  a 
temporarily acceptable use applied to the surface treatment of citrus fruits with montan acid esters at 
levels up to 140 mg/kg fruit; no Acceptable Daily Intake (ADI) was allocated (SCF, 1992).  
In 1996 the Commission received another application for an extended use of montan acid esters to 
cover also uses on confectionery and other foods where other waxes (beeswax, candelilla wax and 
carnauba wax) were authorised (CS/ADD/MsAd/137, dossier EC 137.01).  
The Food Additives Working Group of the SCF discussed the new application between 1996 and 1998 
and concluded that, at a minimum, data should be submitted on an in vitro chromosomal aberration 
study,  reproductive  and  developmental  toxicity  studies  and  a  clear  description  of  the  material, 
including impurities, absence of PAHs and/or a specification. Until now these data have not been 
submitted to EFSA. 
JECFA has not evaluated montan acid esters (these additives were on the agenda of the fifty-third 
meeting, but were removed from the agenda as no information was submitted; JECFA, 1999). Codex 
Alimentarius does not list montan acid esters in its list of food additives
16. 
The SCF also evaluated the montan acid esters as an additive in plastic materials in contact with food 
(FCM). The substance was found acceptable with no  specific migration limit (SML)  (SCF, 1999). 
According to Directive No 2002/72/EC
17, montan acid esters (substance Ref. No 67840) are permitted 
for FCM. 
2.9.  Exposure 
2.9.1.  Food consumption data used for exposure assessment 
In 2010, the EFSA Comprehensive European Food Consumption Database (Comprehensive Database) 
has been built from existing national information on food consumption at a detailed level. Competent 
authorities in the European countries provided EFSA with data on the level of food consumption by 
the individual consumer from the most recent national dietary survey in their country (cf. Guidance of 
EFSA  „Use  of  the  EFSA  Comprehensive  European  Food  Consumption  Database  in  Exposure 
Assessment‟ (EFSA, 2011a). 
Overall, the food consumption data gathered at EFSA were collected by different methodologies and 
thus direct country-to-country comparison should be made with caution. 
For calculation of chronic exposure, intake statistics have been calculated based on individual average 
consumption over the total survey period excluding surveys with only one day per subject. High level 
consumption was only calculated for those foods and population groups were the sample size was 
sufficiently  large  to  allow  calculation  of  the  95
th  percentile  (EFSA,  2011a).  The  Panel  estimated 
chronic exposure for the following population groups: toddlers, children, adolescents, adults and the 
elderly. Calculations were performed using individual body weights. 
Thus, for the present assessment, food consumption data were available from 26 different dietary 
surveys carried out in 17 different European countries as mentioned in Table 3.  
                                                       
16 http://www.codexalimentarius.net/gsfaonline/additives/index.html#M  
17 Commission Directive No 2002/72/EC of 6 August 2002 relating to plastic materials and articles intended to come into 
contact with foodstuffs. OJ L 220, 15.8.2002, p. 18. Re-evaluation of montan acid esters (E 912) as a food additive 
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Table 3:   Population groups considered for the exposure estimates of montan acid esters 
Population  Age range  Countries with food consumption surveys 
covering more than one day 
Toddlers  from  12  up  to  and  including  35 
months of age 
Bulgaria, Finland, Germany, Netherlands 
Children
18  from 36 months up to and including 
9 years of age  
Belgium,  Bulgaria,  Czech  Republic,  Denmark, 
Finland,  France,  Germany,  Greece,  Italy,  Latvia, 
Netherlands, Spain, Sweden  
Adolescents  from  10  up  to  and  including  17 
years of age  
Belgium,  Cyprus,  Czech  Republic,  Denmark, 
France, Germany, Italy, Latvia, Spain, Sweden 
Adults  from  18  up  to  and  including  64 
years of age 
Belgium,  Czech  Republic,  Denmark,  Finland, 
France,  Germany,  Hungary,  Ireland,  Italy,  Latvia, 
Netherlands, Spain, Sweden, UK  
The elderly
18   Older than 65 years  Belgium,  Denmark,  Finland,  France,  Germany, 
Hungary, Italy 
Consumption records were codified according to the FoodEx classification system (EFSA, 2011b).  
Exposure  was  estimated  using  the  food  additives  intake  model  (FAIM),  available  on  the  EFSA 
website
19. 
2.9.2.  Exposure to montan acid esters from its use as food additive 
Exposure to montan acid esters from its use as food additive has been calculated based on information 
contained  in  the  twenty-sixth  series  report  of  the  SCF  (SCF,  1992)  combined  with  national 
consumption data for the five population groups (Table 4). The Panel noted that the peel of the fruit on 
which montan acid esters are permitted, is not normally consumed, except for the rare consumption of 
the peel of citrus fruits as marmalade and as a condiment in food. The Panel further noted that there is 
no information on migration of montan acid esters; however, the Panel considered that due to the high 
molecular weight and the lipophilicity of the substance, migration through the peel is likely to be 
negligible.  
Therefore, in the present exposure estimation, only the exposure via the peel of citrus fruits is taken 
into account. The exposure from the use of citrus peel as a condiment in food is considered negligible. 
The Panel noted that its estimates should be considered as being conservative as it is assumed that: 
1) all citrus fruit contains montan acid esters at a level of 140 mg/kg fruit according to the SCF,  
2) all “jams, marmalades and other fruit spreads” consumed are citrus fruit marmalade, and  
3) citrus marmalade has a citrus fruit content of 60 % (including peels).  
Table 4 summarises the estimated exposure to montan acid esters from its use as food additive of all 
five population groups. 
                                                       
18 The terms “children” and “the elderly” correspond respectively to “other children” and the merge of “elderly” and “very 
elderly” in the Guidance of EFSA on the „Use of the EFSA Comprehensive European Food Consumption Database in 
Exposure Assessment‟ (EFSA, 2011b). 
19 (http://www.efsa.europa.eu/en/topics/topic/additives.htm). Re-evaluation of montan acid esters (E 912) as a food additive 
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Table 4:   Summary of anticipated exposure to montan acid esters from its use as food additive using 
reported use levels (140 mg/kg) in five population groups (mg/kg bw/day)  
 
Toddlers  Children  Adolescents  Adults  Elderly 
 
(12-35 months)  (3-9 years)  (10-17 years)  (18-64 years)  (>65 years) 
Estimated exposure using highest application rate cited in literature 
Mean exposure  0.003-0.01  0.002-0.03  0.001-0.01  0.003-0.01  0.003-0.02 
Exposure 95
th percentile  0.08-0.18  0.04-0.18  0.03-0.12  0.03-0.09  0.04-0.09 
For estimates derived using a use level of 140 mg/kg reported by the SCF (1992), mean intake of 
montan  acid  esters  from  use  as  food  additives  ranged  from  0.001-0.03  mg/kg  bw/day  across  all 
population groups. High intake estimates ranged from 0.03-0.18 mg/kg bw/day across all population 
groups. 
2.10.  Uncertainty analysis 
Uncertainties in the exposure assessment of acid montan esters have been previously discussed in the 
present opinion, in the previous chapter. According to the guidance provided in the EFSA opinion 
related  to  uncertainties  in  dietary  exposure  assessment  (EFSA,  2007),  the  following  sources  of 
uncertainties have been considered and summarised below: 
Table 5:   Qualitative evaluation of influence of uncertainties 
Sources of uncertainties  Direction 
* 
Consumption data: different methodologies / representativeness / under 
reporting / misreporting / no portion size standard  +/- 
Extrapolation  from  food  consumption  survey  of  few  days  to  estimate 
chronic exposure  + 
Linkage between reported use levels and food items in the consumption 
database:  uncertainties  on  which  precise  types  of  food  the  use  levels 
refer. 
+/ 
Occurrence data: maximum reported use levels within a food category  + 
Exposure model: uncertainty in possible national differences in use levels 
of food categories, data set not fully representative of foods on the EU 
market, exposure calculations based on the maximum reported use levels 
(no use of typical use levels when available) 
+ 
* + = uncertainty with potential to cause over-estimation of exposure;  
- = uncertainty with potential to cause 
3.  Biological and toxicological data 
No new toxicological or biological information was submitted following the public call for data in 
2012.  
A  literature  search  was conducted  on  montan acid esters in  the  most  commonly  available  online 
databases  for  toxicological  and  biological  information  (PubMed,  Toxline,  BIOSIS  and  Web  of 
Science), but no relevant new information was identified.  
Montan  acid  esters  have  been  evaluated  previously  by  the  SCF  (SCF,  1992)  and  by  TemaNord 
(TemaNord,  2002).  The  present  opinion  briefly  describes  the  major  studies  evaluated  in  these 
opinions. Re-evaluation of montan acid esters (E 912) as a food additive 
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3.1.  Absorption, distribution, metabolism and excretion  
No data on ADME of montan acid esters were available for the present evaluation; no data were 
available to the SCF in 1992; no data were submitted following a call for data.  
3.2.  Toxicological data
20 
3.2.1.  Acute oral toxicity  
LD50 values of more than 20 000 mg/kg bw were obtained in oral studies with albino mice for two 
types of montan acid esters [Wax E: mixture of mono- and diesters of montan acids with ethylene 
glycol (CAS Registry Number 73138-45-1) and Wax OP: montan wax acid butylene glycol diester, 
CAS Registry Number 93763-20-3 with added calcium hydroxide (about 2 % CaO)]. Each of the test 
mixture was administered by gavage as a 20 % suspension in starch mucilage, to 10 cross-bred albino 
mice of unspecified sex. The animals received the highest administrable dose of 20 g wax/kg bw. This 
amount was well tolerated by all the mice. The mice were observed for 6 days after application, and 
none of the animals died (Anon, 1963; Scholz and Weigand, 1963).  
An LD50 value of more than 15 000 mg/kg bw in rats has been reported for another type of montan 
acid esters [Wax KPS: mixture of mono- and diesters of montan acids with equimolar parts of ethylene 
glycol and 1,3-butylene glycol (CAS Registry number 73138-44-0)] by Scholz and Weigand (1969). 
No other studies on the acute toxicity of montan acid esters were identified in the literature. 
3.2.2.  Short-term and subchronic toxicity  
Leist (1980) tested montan acid ester [Wax WE4: mixture of mono-, di- and tri-esters of montan acids 
with glycerol (CAS Registry Number 68476-38-0)]  in a 90-day subchronic toxicity study in SPF 
Wistar rats. No information was given on whether the tests were carried out according to OECD 
guidelines and/or Good Laboratory Practice (GLP). Four groups of 15 rats of each sex received a diet 
containing the test substance at concentrations of 0, 2000, 10 000 and 50 000 mg/kg feed (equivalent 
to 0, 147, 743 and 3916 mg test substance/kg bw/day for the males and 0, 160, 787 and 4090 mg test 
substance/kg bw/day for the females, as calculated by the authors based on feed intake). Behaviour 
and state of health were examined daily except on weekends, and body weight and feed consumption 
were  measured twice  a  week.  Haematological  and clinical-chemical  analyses  and  urinalyses  were 
performed in the middle (exact time not further specified by the authors) and at the end of the study. 
At the post-mortem examinations the animals were examined macroscopically for changes in organs, 
and the heart, lungs, liver, kidneys, spleen, testicles/ovaries, adrenal glands, thyroid gland, brain and 
pituitary gland were weighed and their relative organ weights were calculated. Microscopic slides 
were prepared from organs and tissues of all the animals. Histopathological examination was carried 
out on the organs of the controls and of the highest dose groups, as well as any organs from other 
groups which showed macroscopic changes. The behaviour, state of health, body weight gain and 
feed/water consumption were not affected by the test substance. Significant differences were observed 
in  several  of  the  haematological  parameters  compared  to  the  controls.  The  Panel  noted  that 
haemoglobin was increased in both sexes, and there were increases in erythrocytes in males receiving 
10 000 mg/kg diet and 50 000 mg/kg diet, and in leucocytes in males at the highest dose in the middle 
of  the  study.  Significant  increases  in  haemoglobin,  leucocytes  and  erythrocytes  in  males,  and  in 
leucocytes  in  females  at  the  highest  dose,  were  also  observed  at  the  end  of  the  study.  All  the 
haematological changes were within the normal range of biological variation, and the differential 
white  cell  counts  exhibited  no  changes.  Furthermore,  no  pathological  changes  were  found  in  the 
haematopoietic organs.  
Significant changes were found in several clinical chemical parameters. Alkaline phosphatase was 
increased  in  males  receiving  the  test  substance  at  10  000  mg/kg  diet,  and  serum  potassium  was 
decreased  in  males  receiving  2000  g/kg  diet.  Urea  and  uric  acid  were  decreased  and  increased, 
respectively, in males receiving the test substance at 50 000 mg/kg diet; in females, urea was increased 
                                                       
20 Information on the waxes used in the toxicological studies is listed in Annex 1.  Re-evaluation of montan acid esters (E 912) as a food additive 
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at the dose of 10 000 mg/kg diet, and potassium was increased in females receiving 50 000 mg/kg diet. 
However, all recorded changes within the groups receiving the test substance were within the normal 
range for the strain of rats used, and were thus not interpreted to be biologically relevant. There were 
no abnormal urinalysis findings. At the post-mortem examinations, no treatment-related statistically 
significant  changes  were  found  in  organ  weights  and  no  adverse  macroscopic  differences  were 
detected.  
The authors concluded that in the rat, no treatment-related effect from the administration of the test 
substance was observed up to dose levels of about 50 000 mg test substance/kg diet for 90 days, 
corresponding to 3916 mg/kg bw/day for males and 4090 mg/kg bw/day for females as calculated by 
the authors. The Panel agreed with this conclusion. 
In a study in Beagle dogs (4 males and 4 females/dose), two types of montan acid esters (Wax E and 
Wax OP) were tested in short-term toxicity tests. The respective test substances were mixed in the diet 
at concentrations of 5000, 20 000 and 50 000 mg/kg feed (corresponding to 200, 735 and 1600 mg/kg 
bw/day and 173, 644 and 1660 mg/kg bw/day for the two products respectively; values calculated as 
average dose from the test diet consumed). A non-nutritive cellulose-like substance
21 was used in the 
diet of the control animals. The diet was given  ad libitum for one hour a day, seven days a week for 
140 days. 
Two dogs, one exposed to Wax E at a level of 5000 mg/kg feed and the other exposed to Wax OP at a 
level of 50 000 mg/kg feed, lost and gained weight sporadically throughout the investigation, but all 
the other dogs appeared normal. No significant differences were found in the average body weights of 
each group of dogs or the amount of food consumed. No significant differences were found between 
the groups with respect to the haematology and clinical chemistry results. No treatment-related effects 
appeared in the urinalysis or in the macroscopic post-mortem examination. Moreover, the ratios of the 
weights  of  various  organs  to  body  weight  were  within  normal  limits  and  were  not  significantly 
different among the groups. It was concluded by the authors that no significant effects were produced 
by either of the waxes in the study (Doerr et al., 1967). The Panel agreed with this conclusion. 
In another study with the same design as above, Beagle dogs (4 males and 4 females/dose) and 4 of 
each sex as untreated control, received montan acid esters (Wax KPS) in their feed, at the same dose 
levels as above, for 90 consecutive days. None of the measured parameters (feed consumption, body 
weight, blood, serum, blood glucose, enzyme activity, urine, histopathological examination of the eye, 
together with N. opticus, and other organs) showed any treatment-related effects (Scholz and Brunk, 
1967). 
No other short-term or subchronic toxicity studies are available on montan acid esters. 
3.2.3.  Genotoxicity  
In vitro assays 
Two types of montan acid esters (Wax E and Wax WE4) were tested for their mutagenic potential in 
Salmonella typhimurium strains TA1535, TA1537, TA1538, TA98 and TA100, and in Escherichia 
coli strain WPuvrA. Concentrations of 4, 20, 100, 500, 2500 and 10 000 μg/plate were tested, and the 
tests were performed with (S-9 fraction of Aroclor 1254-induced Sprague-Dawley rats) and without 
metabolic activation. The test was carried out according to guideline OECD 471. No bacterial toxicity 
was observed, but visible precipitation of the test substances on the plates was observed with 500 
μg/plate of WE4 and 2500 μg/plate of Wax E. For the second experiment, 2500 μg/plate of Wax WE4 
and 5000 μg/plate of Wax E were chosen as the highest doses. No bacterial mutagenicity was observed 
in any of the tests with or without metabolic activation (Jung and Weigand, 1986; Müller, 1987). 
                                                       
21 Alphacel: a polysaccharide linked with 4-O-beta-D-Glucopyranosyl-D-glucose units (as in cellobiose). Re-evaluation of montan acid esters (E 912) as a food additive 
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3.2.4.  Chronic toxicity and carcinogenicity  
Studies with montan ester waxes 
Scholz and Weigand (1963) tested montan acid esters (Wax E) in a 2-year chronic toxicity study in 
groups of 25 cross-bred albino rats of each sex. The test mixture was mixed in the pelleted diet, which 
the rats received daily (7 days a week) as the only feed. The diet contained the test substances in 
concentrations of 0, 5000, 20 000 and 50 000 mg/kg feed (corresponding to 225, 900 and 2250 mg/kg 
bw/day for the males and to 290, 1160 and 2900 mg/kg bw/day for the female rats). The weight of 
each animal was monitored once a week in the first 4 weeks of the trial and then at 14-day intervals. 
The behaviour of the animals and the general state of health of each animal was checked each day. 
Haematology (15/sex/dose; haemoglobin, erythrocyte, leucocyte) and urinalysis (15/sex/dose; protein, 
appearance, sediment) was examined at the beginning of the study, 2 times during the study and at the 
end of the study. Absolute and relative organ weights (all animals; heart, lung, liver, kidney, spleen), 
gross  pathology  (all  animals)  and  histology  (all  animals;  heart,  lung,  liver,  kidney,  spleen)  were 
evaluated. 
After 15 and 28 weeks no abnormalities were found. No detailed data of females after 15 weeks and 
no detailed data of males after 28 weeks for haematology and urinalysis were given. After 104 weeks 
40 males and 30 females had died during the study (scattered throughout all groups including the 
control  group),  mostly  because  of  pulmonary  infections.  Urinalysis  showed  erythrocytes  in  the 
sediment for 3, 4 and 5 animals in respectively the 5000, 20 000 and 50 000 mg/kg feed dose group; 
the controls showed no erythrocytes in the sediment. An increase in proteins in the urine was seen 
through all groups including the control group. Haematology, organ weights, gross pathology and 
histology showed no abnormalities. Tumours occurred at about the same frequency in all groups. The 
majority of the tumours were fibroadenomas of the mammary glands. The authors concluded that the 
results indicate that administration of the two types of montan acid ethylene glycol diester (Wax E) in 
the feed, up to concentrations of 50 000 mg/kg for two years, did not lead to any sign of treatment-
related toxic effects.  
In another study (Anon., 1963), montan acid esters (Wax OP) was tested in a 2-year chronic toxicity 
study in 4 groups of 25 cross-bred albino rats of each sex. The test mixture was mixed in the pelleted 
diet, which the rats received daily (7 days a week) as the only feed. The diet contained the test 
substances in concentrations of 0, 5000, 20 000 and 50 000 mg/kg feed (equivalent to 225, 900 and 
2250 mg/kg bw/day for the males and to 290, 1160 and 2900 mg/kg bw/day for the female rats). After 
15 weeks and after 28 weeks 5 animals/sex/dose were sacrificed. After 104 weeks all the surviving 
animals were sacrificed. All animals in the test groups were fed normally (the control diet) for 5 to 9 
days prior to sacrifice. Clinical observations and feeding behaviour was controlled daily. Body weight 
of each animal was monitored once a week in the first 4 weeks of the trial and then at 14-day intervals. 
Haematology  (15/sex/dose;  haemoglobin,  red  and  white  cell  count,  differential  cell  count)  and 
urinalysis (same 15/sex/dose; protein, appearance, sediment) was examined at the beginning of the 
study, two times during, and at the end of the study. Absolute and relative organ weights (all animals; 
heart, lung, liver, kidney, spleen), gross pathology (all animals) and histology (all animals; heart, lung, 
liver, kidney, spleen) were evaluated. At 15 weeks the exposed males showed increased protein-levels 
in the urine. According to the authors this effect was also seen in the control group, however the 
detailed  haematology  and  urinalysis  data  of  females  and  controls  at  15  weeks  and  of  males  and 
controls at 28 weeks were not given. At 28 weeks one female of the 20 000 mg/kg feed dose-level had 
died during the study. After 104 weeks 34 males and 35 females had died during the study (scattered 
throughout all dose groups and the control group), mostly because of pulmonary infections. Urinalysis 
showed erythrocytes in the sediment for 2, 2 and 3 animals in respectively the 5000, 20 000 and 50 
000 mg/kg feed dose group; this effect was not seen in the control group. Other differences between 
exposed animals and controls were not found. 
Tumours occurred at about the same frequency in all groups. Even in the 50 000 mg/kg feed group, the 
tumour frequency was not higher than in the lower dosage groups. The majority of the tumours were Re-evaluation of montan acid esters (E 912) as a food additive 
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fibroadenomas of mammary glands. The authors concluded that the results indicate that administration 
of montan acid esters (Wax OP) in the feed, up to concentrations of 50 000 mg/kg for two years, did 
not lead to any sign of treatment-related toxic effects. 
The Panel noted the limitations for both studies as regards the low numbers of surviving animals per 
group, high number of animals with pulmonary infections and the associated death, no detailed data on 
haematology and urine analyses and the limited number of organs (5) evaluated histopathologically. 
The Panel considered  that these limitations introduced such a high level of  uncertainty that these 
studies were not suitable for risk assessment. 
Scholz and Weigand (1969), in a similar study as those described above, tested Wax KPS. Wax KPS is 
a mixture of the esters of the chromic acid oxidation product of crude montan wax  with ethylene 
glycol and 1.3-butylglycol (1:1), the impurities are K2SO4 (0.1 %) and Cr2(SO4)3. In this study groups 
of 40 Wistar rats/sex/dose were fed a standard diet for two years containing 0, 10 000 or 50 000 mg 
test substance/kg diet (corresponding, on average, to about 0, 690 or 3300 mg/kg bw/day for males 
and 0, 690 and 3800 mg/kg bw/day for females, calculated from the food intake data). No compound-
related  effects  were  noted  on  body  weight  gain,  haematology,  urinalysis,  and  organ  weights. 
Macroscopically, inflammation and sporadic tumours were found in the lungs in controls and also in 
the treated animals. Histopathological evaluation was done on a wide range of organs and tissues 
(heart,  liver,  kidney,  adrenal  gland,  lung,  spleen,  cerebrum,  cerebellum,  N.  Opticus,  testicles, 
epididymis, ovary, uterus, pancreas, small intestine, colon, thymus, urinary bladder). No treatment 
related effects were observed. The Panel noted that the specification for the test compound did not 
appear to be entirely consistent with that set forward by Commission Regulation No 231/2012 for 
montan acid esters (E 912), particularly in terms of chromium content. Therefore the Panel considered 
that,  based  on  the  information  available,  the  study  cannot  provide  a  suitable  basis  for  the  risk 
assessment of montan acid esters (E 912). 
3.2.5.  Reproductive and developmental toxicity 
No studies on reproductive and developmental toxicity on montan acid esters were submitted to the 
SCF or identified in the literature search. No data were submitted following a public call for data in 
2012 (http://www.efsa.europa.eu/en/dataclosed/call/120215a.htm). 
3.2.6.  Hypersensitivity 
No  studies  on  the  hypersensitivity  of  montan  acid  esters  were  available  or  identified  in  a  recent 
literature search. 
4.  Discussion 
The Panel was not provided with a newly submitted dossier on montan acid esters and no new data 
were  submitted  following  a  public  call  for  data.  The  present  evaluation  is  based  on  previous 
evaluations and on additional literature that became available since then. Not all original studies on 
which previous evaluations were based were available for re-evaluation, but the Panel had access to 
information submitted to SCF. 
Montan acid esters (E 912) are waxes of various chemical compositions. Montan acids are isolated 
from montan wax, a bituminous product extracted from lignite, and then esterified with diols such as 
ethylene glycol and 1,3-butylene glycol or with triols such as glycerol. 
The Panel noted that benzene is used as solvent in the manufacturing process. Benzene is genotoxic 
and is classified by IARC and EU as a human carcinogen. The Panel recommended that benzene 
should not be used for the manufacturing of montan acid esters. 
The Panel noted that the specifications did not include properties such as melting point and solubility, 
which would help identify  the substance. The Panel considered that the starting  materials for the Re-evaluation of montan acid esters (E 912) as a food additive 
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production of the montan acid esters would justify either a requirement for limits for PAHs, or proof 
that the extraction procedure and the subsequent oxidation steps in the manufacturing process would 
prevent any residual contamination with such substances. 
No data on ADME of montan acid esters were available for the present evaluation. 
Feeding studies in the dog and the rat have been performed with different types of test mixtures that 
fall within the definition of montan acid esters, E 912. In a 90-day study in the rat and in two 90-day 
studies in the dog no treatment related effects were found at doses up to 1660 mg/kg bw/day for the 
dog and up to about 4000 mg/kg bw/day for the rat.  
The Panel considered that the two 2-year studies on montan acid esters (Wax E and Wax KPS) were 
not suitable for risk assessment due to the limitations in the studies or the material tested as described 
earlier.  
Two types of commercial montan acid esters (Wax E and  Wax WE4) gave negative results in the 
Ames test.  
No reproductive and developmental toxicity studies are available. 
The Panel noted that: 
-  no data on toxicokinetics and reproductive and developmental toxicity of montan acid esters 
were available, 
-  the available data on short-term and subchronic toxicity, genotoxicity and chronic toxicity and 
carcinogenicity were limited, 
-  the data requested by the SCF in the late 1990s (i.e. chromosomal aberration study in vitro, 
reproduction  and  teratogenicity  studies,  description  of  the  material,  including  impurities, 
absence of PAHs and/or a specification) have not been submitted.  
-  No data were submitted following an EFSA public call for data in 2012. The Panel identified 
some  summary  data  in  the  ECHA  database  on  registered  substances  that  might  have  been 
relevant for the assessment of montan acid esters but the original study reports were not made 
available to EFSA. 
Based on these limitations in the toxicological database the Panel concluded that montan acid esters as 
a food additive could not be evaluated. 
CONCLUSIONS  
Based on these limitations in the toxicological database the Panel concluded that montan acid esters as 
a food additive could not be evaluated. 
The Panel noted that benzene is reported to be used as solvent in the manufacturing process. Benzene 
is not authorised as an extraction solvent in the production of foodstuffs and ingredients (EU Directive 
No 2009/32/EU). Benzene is genotoxic and is classified by the International Agency for Research on 
Cancer  (IARC)  and  EU  as  a  human  carcinogen  and  therefore  it  should  not  be  used  for  the 
manufacturing of montan acid esters. 
DOCUMENTATION PROVIDED TO EFSA 
1.  Pre-evaluation document prepared by DTU Food, National Food Institute (Technical University of 
Denmark). November 2010. Re-evaluation of montan acid esters (E 912) as a food additive 
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GLOSSARY AND/OR ABBREVIATIONS 
ADI  Acceptable Daily Intake  
ANS  Scientific Panel on Food Additives and Nutrient Sources added to Food 
AV  Acid Value 
CAS  Chemical Abstracts Service 
DS  Dry Substance 
DSC  Differential Scanning Calorimetry  
EC  European Commission 
ECHA  European Chemicals Agency  
EU  European Union 
EFSA  European Food Safety Authority 
FCM  Materials in contact with food; Food contact materials 
GLP  Good Laboratory Practice  
IARC  International Agency for Research on Cancer 
JECFA  Joint FAO/WHO Expert Committee on Food Additives  
LD50  Lethal Dose, 50 % i.e. dose that causes death among 50 % of treated animals 
MPL  Maximum Permitted Level 
NOAEL  No-Observed-Adverse-Effect Level 
OECD  Organisation for Economic Co-operation and Development  
PAHs  Poly-Aromatic Hydrocarbons  
SCF  Scientific Committee on Food 
SML  Specific Migration Limit  
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ANNEX 1 
Substances used in the toxicological studies 
Name  CAS Registry 
number 
EINECS 
number  Chemical formula  Toxicity studies 
Wax E  73138-45-1  277-291-8  Ethylene glycol 
monomontanate (C30H60O3) 
Chronic toxicity and 
carcinogenicity.  
Reproductive and 
developmental toxicity 
Wax KPS  73138-44-0  277-290-2 
Mixture of mono- and 
diesters of montan acids 
with equimolar parts of 
ethylene glycol and 1,3-
butylene glycol 
 
Acute toxicity 
Chronic toxicity and 
carcinogenicity 
Wax OP  93763-20-3  297-837-9  Partially saponified 1,3-
butanediol montanate  
Chronic toxicity and 
carcinogenicity 
Wax WE 4   68476-38-0   
Mixture of mono-, di- and 
tri-esters of montan acids 
with glycerol  
Genotoxicity in vitro  
 